Nutriband Sells 90% Stake in Pocono Pharmaceutical for $5 Million
- Stake Sale: Nutriband has agreed to sell a 90% stake in its subsidiary Pocono Pharmaceutical for $5 million, which will provide the company with capital to support the development of its core products.
- Continued Investment: Proceeds from the sale will be directed towards the ongoing development of AVERSA Fentanyl, which has the potential to become the world's first abuse-deterrent opioid patch, with projected annual sales ranging from $80 million to $200 million.
- Shareholder Retention: Following the transaction, Nutriband shareholders will retain a 10% stake in EarthVision Bio, ensuring continued shareholder interest and potentially providing an additional revenue stream for future growth.
- Sustainability Focus: EarthVision Bio's development of sustainable products aims to replace plastics and other traditional materials, aligning with the growing market demand for eco-friendly alternatives and enhancing Nutriband's strategic position in the sustainability sector.
Trade with 70% Backtested Accuracy
Analyst Views on INTC
About INTC
About the author

- Share Reduction Details: According to an SEC filing dated February 17, 2026, Paloma Partners Management Co reduced its holdings in Core Scientific by 2,547,000 shares, with an estimated transaction value of $44.41 million, reflecting a $46.32 million decline in the fund's position value over the quarter, indicating the impact of market volatility on its investment portfolio.
- Current Holdings Analysis: Following the sale, Core Scientific now accounts for only 0.49% of Paloma Partners' reportable U.S. equity assets, with its remaining 185,000 shares valued at $2.69 million at year-end, suggesting a significant reduction in the company's importance within the portfolio.
- Market Performance Overview: As of February 17, 2026, Core Scientific shares were priced at $17.23, reflecting a 39.1% increase over the past year, outperforming the S&P 500 by 25.81 percentage points, demonstrating the company's relative strength in the digital asset market.
- Business Model and Risks: Core Scientific generates revenue through self-mining and equipment hosting, and while its stock price reflects improving crypto sentiment, its profitability remains tied to production efficiency and power costs, necessitating investor attention on key metrics like Bitcoin production efficiency and power cost management.
- Market Weakness: The S&P 500 index fell by 0.28%, the Dow Jones Industrial Average decreased by 0.54%, and the Nasdaq 100 index dropped by 0.41%, indicating market concerns over the outlook for artificial intelligence, particularly affecting chipmakers and AI infrastructure stocks.
- Mixed Economic Data: Initial jobless claims in the US fell to 206,000, a 5-week low, indicating a strong labor market; however, the December trade deficit widened to $70.3 billion, exceeding expectations, reflecting uncertainties in economic recovery.
- Shifts in Fed Policy Expectations: Hawkish comments from Fed officials suggest a potential need for interest rate hikes to combat persistent inflation, leading to a more hawkish outlook for future rate paths, which further dampens market sentiment.
- Earnings Season Nearing Conclusion: With over three-quarters of S&P 500 companies reporting, 74% exceeded expectations, and Q4 earnings are projected to grow by 8.4%, demonstrating corporate resilience, yet the market remains cautious about future growth prospects.
- Market Weakness: The S&P 500 index fell by 0.26%, the Dow Jones Industrial Average by 0.28%, and the Nasdaq 100 by 0.34%, reflecting market concerns over the outlook for artificial intelligence, particularly with poor performances from chipmakers and AI infrastructure stocks.
- Mixed Economic Data: Initial jobless claims in the US fell by 23,000 to 206,000, marking a 5-week low and indicating a strong labor market; however, the December trade deficit widened to $70.3 billion, exceeding expectations and suggesting challenges in economic recovery.
- Earnings Season Nearing End: Over 75% of S&P 500 companies have reported earnings, with 75% exceeding expectations, and Q4 earnings growth is projected at 8.4%, marking the tenth consecutive quarter of year-over-year growth, demonstrating resilience in corporate earnings.
- Geopolitical Risks Intensify: WTI crude oil prices rose over 2% to a three-week high due to military buildup in the Middle East, potentially increasing inflationary pressures, which could affect market sentiment and investor confidence.
- Consumer Impact of Tariffs: The current average effective tariff rate in the U.S. stands at 16.9%, the highest since 1932, with projections indicating that consumers will pay an additional $1,300 to $1,700 in 2026, significantly increasing household economic burdens.
- Potential Legal Changes: Should the Supreme Court rule IEEPA tariffs unconstitutional, the consumer burden could be halved to between $600 and $800, providing some economic relief for families and influencing future spending patterns.
- Tariff Revenue Analysis: U.S. Customs and Border Protection collected approximately $133.5 billion in tariff revenue in fiscal year 2025, accounting for 60% of total tariff revenue during that period, highlighting the significant impact of tariff policies on government finances.
- Alternative Tariff Pathways: The Trump administration may resort to other legal frameworks to continue imposing tariffs, and economists note that even if IEEPA is overturned, this will limit potential consumer relief while maintaining high tariff burdens.
- Market Decline: The S&P 500 Index fell by 0.44%, the Dow Jones by 0.57%, and the Nasdaq 100 by 0.66%, reflecting market concerns over the outlook for artificial intelligence, particularly impacting chipmakers and AI infrastructure stocks.
- Mixed Economic Data: Weekly initial jobless claims dropped to 206,000, a five-week low, indicating a strong labor market; however, the December trade deficit widened to $70.3 billion, exceeding expectations, suggesting economic pressures that could affect market confidence.
- Earnings Season Nearing End: Over 75% of S&P 500 companies have reported earnings, with 75% exceeding expectations, and Q4 earnings growth projected at 8.4%, providing some support for the market, although overall sentiment remains cautious.
- Geopolitical Risks Intensify: WTI crude oil prices rose over 1% to a three-week high due to U.S. military buildup in the Middle East, heightening inflation concerns and potentially increasing expectations for Fed rate hikes.
NVIDIA's Recent 13F Filing: NVIDIA has released its latest 13F SEC filing, revealing its investments and trades during Q4 2025, highlighting its strategic moves in the AI and semiconductor sectors.
Intel and Synopsys Holdings: Intel and Synopsys have become NVIDIA's top holdings, with NVIDIA increasing its exposure to these companies, which are crucial in the electronic design automation industry.
Market Impact and Stock Performance: Following NVIDIA's filing, Intel's stock surged nearly 50%, benefiting from NVIDIA's $2 billion purchase of shares, while Synopsys also saw a significant increase in its stock value.
Strategic Partnerships: NVIDIA is deepening its relationships with Intel and Synopsys, focusing on strategic alignment to enhance its position in the CPU market and accelerate design processes, while also divesting from smaller companies.











